Literature DB >> 14604898

Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes.

Weijia Wu1, Siqing Song, David L Ashley, Clifford H Watson.   

Abstract

Bidi cigarettes, or bidis, are a tobacco product that originated in India and have been gaining popularity in the USA during the past few years, particularly with adolescents. As with conventional cigarettes, tobacco and smoke from bidis contain chemical constituents including carcinogenic chemicals such as the tobacco-specific nitrosamines (TSNAs). To help better assess the potential public health risk associated with bidi cigarettes, we developed modern high throughput methods to accurately quantify TSNA levels in tobacco and mainstream cigarette smoke particulate. We determined the TSNA levels in the tobacco filler and mainstream smoke from 14 bidi cigarette brands. In the bidi tobacco filler, the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) levels ranged from 0.09 to 0.85 microg/g, while N'-nitrosonornicotine (NNN) levels ranged from 0.15 to 1.44 microg/g. These amounts are comparable with those in typical American blended cigarettes. The levels of NNK in mainstream smoke from bidis ranged from 2.13 to 25.9 ng/cigarette, and NNN levels ranged from 8.56 to 62.3 ng/cigarette. The wide variation in the TSNA levels most probably reflects the hand-rolled nature of the bidi cigarettes, resulting in a product with less homogenous tobacco amount and a wider variation in overall cigarette construction quality. TSNA levels of bidis were comparable with those of conventional cigarettes, and bidis should not be considered a lower-risk alternative tobacco product. Our analytical findings concur with the previous biologic and biochemical evidence supporting epidemiologic studies linking bidi use with various cancers, especially oral cavity and lung cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604898     DOI: 10.1093/carcin/bgh004

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

Review 1.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

2.  Gastric cancer risk in relation to tobacco use and alcohol drinking in Kerala, India--Karunagappally cohort study.

Authors:  Padmavathy Amma Jayalekshmi; Soroush Hassani; Athira Nandakumar; Chihaya Koriyama; Paul Sebastian; Suminori Akiba
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

3.  Concept of BIDI years: Relevance to the perioperative period.

Authors:  Rashmi Datta; Shalendra Singh; Arjun Joshi; Vikas Marwah
Journal:  Lung India       Date:  2022 Jul-Aug

4.  Patterns and related factors of bidi smoking in India.

Authors:  Lazarous Mbulo; Krishna M Palipudi; Tenecia Smith; Shaoman Yin; Vineet G Munish; Dhirendra N Sinha; Prakash C Gupta; Leimapokpam Swasticharan
Journal:  Tob Prev Cessat       Date:  2020-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.